2018 International Congress

Saturday, October 6, 2018

1:45pm-3:15pm

A wireless brain-spine interface alleviating gait deficits of non-human primates model of Parkinson’s disease

F. Raschella, T. Milekovic, M. Perich, S. Sun, G. Schiavone, C. Hitz, Y. Jianzhong, W. Ko, Q. Li, C. Qin, S. Lacour, J. Bloch, S. Micera, E. Bezard, G. Courtine (Geneva, Switzerland)

Surgical Therapy: Parkinson's Disease  ·  Hall 3FG

1:45pm-3:15pm

Abnormal signaling along the non-canonical molecular cascade GRK6/β-arrestin2/Akt/GSK-3β in the putamen is associated with tardive dyskinesia following chronic haloperidol exposure in a primate model

P. Blanchet, G. Hernandez, S. Mahmoudi, M. Cyr, J. Diaz, D. Levesque (Montreal, QC, Canada)

Drug-Induced Movement Disorders  ·  Hall 3FG

1:45pm-3:15pm

Abrogation of Rotenone Induced Behavior, Biochemical and Mitochondrial Deficits in Mice by Curcumin and Ginkgo Biloba: New Combinational Therapy Approach for Parkinson’s Disease

D. Khatri, M. Panchwadkar, P. Rane, V. Undale (Pune, India)

Neuropharmacology  ·  Hall 3FG

1:45pm-3:15pm

Absence of wearing-off in Parkinson’s disease patients with treatment beyond 10 years

Q. Wei, R. Ou, Y. Wu, X. Yuan, Y. Hou, H. Liu, L. Zhang, Y. Chen, B. Cao, X. Chen, H. Shang (Chengdu, China)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG

1:45pm-3:15pm

Activities of Daily Living and Quality of Life in Patients with Advanced Parkinson’s Disease Who Are Treated with or Planning to Use Device-Aided Treatments

A. Fasano, K. Seppi, V. Fung, Z. Pirtosek, J.C. Parra, L. Bergmann, O. Sanchez-Soliño, B. Elibol, K. Onuk (Toronto, ON, Canada)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG

1:45pm-3:15pm

Acute efficacy and tolerability of the COMT inhibitor opicapone

F. Gandor, D. Sykora, D. Gruber, G. Ebersbach (Beelitz-Heilstätten, Germany)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG

1:45pm-3:15pm

Advanced Parkinson’s disease Diagnosis and Treatment Trends in Israel – Sub-Analysis of the OBSERVE-PD Multi-Country, Cross-Sectional Study

R. Djaldetti, S. Hassin-Baer, M. Anca-Herschkovitsch, R. Gross, R. Cohen, H. Banayan, K. Onuk, T. Gurevich (Petah Tikva, Israel)

Clinical Trials and Therapy in Movement Disorders  ·  Hall 3FG

1:45pm-3:15pm

After Deep Brain Stimulation Surgery for Parkinson’s Disease risk Factors for Postoperative Delirium

F. Rakhimov, G. Rakhimbaeva (Tashkent, Uzbekistan)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG

1:45pm-3:15pm

Age related changes of cortical effective connectivity during bimanual motor control

P. Loehrer, F. Nettersheim, I. Weber, F. Jung, L. Timmermann (Marburg, Germany)

Neurophysiology (Non-PD)  ·  Hall 3FG

1:45pm-3:15pm

Alleviation of freezing of gait in patients with Parkinson’s disease by high-frequency rTMS over SMA is associated with normalization of brain connectivity patterns

T.M. Mi, S. Garg, F. Ba, T. Wu, P.P. Liang, L.L. Gao, K.C. Li, P. Chan, M. McKeown (Beijing, China)

Clinical Trials and Therapy in Movement Disorders  ·  Hall 3FG